Multi-target-directed ligands to combat neurodegenerative diseases

A Cavalli, ML Bolognesi, A Minarini… - Journal of medicinal …, 2008 - ACS Publications
Our understanding of the pathogenesis of diseases has advanced enormously in recent
decades. As a consequence, drug discovery has gradually shifted from an entirely …

Neurodegenerative diseases and oxidative stress

J Emerit, M Edeas, F Bricaire - Biomedicine & pharmacotherapy, 2004 - Elsevier
Oxidative stress is now recognized as accountable for redox regulation involving reactive
oxygen species (ROS) and reactive nitrogen species (RNS). Its role is pivotal for the …

Minocycline selectively inhibits M1 polarization of microglia

K Kobayashi, S Imagama, T Ohgomori, K Hirano… - Cell death & …, 2013 - nature.com
Minocycline is commonly used to inhibit microglial activation. It is widely accepted that
activated microglia exert dual functions, that is, pro-inflammatory (M1) and anti-inflammatory …

[图书][B] What's wrong with my mouse?: behavioral phenotyping of transgenic and knockout mice

JN Crawley - 2007 - books.google.com
Dr. Jacqueline N. Crawley, author of the First and Second Editions of What's Wrong with My
Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice, continues to field calls …

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study

MR Turner, A Cagnin, FE Turkheimer, CCJ Miller… - Neurobiology of …, 2004 - Elsevier
Microglial activation is implicated in the pathogenesis of ALS and can be detected in animal
models of the disease that demonstrate increased survival when treated with anti …

Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain

M Lalancette-Hébert, G Gowing, A Simard… - Journal of …, 2007 - Soc Neuroscience
Here we report in vivo evidence of a neuroprotective role of proliferating microglial cells in
cerebral ischemia. Using transgenic mice expressing a mutant thymidine kinase form of …

A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?

MC Bellingham - CNS neuroscience & therapeutics, 2011 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is a devastating and fatal neurodegenerative disease of
adults which preferentially attacks the neuromotor system. Riluzole has been used as the …

The promise of minocycline in neurology

VW Yong, J Wells, F Giuliani, S Casha… - The Lancet …, 2004 - thelancet.com
The capacity of minocycline to alleviate disease for several neurological disorders in
animals is increasingly being recognised. Indeed, that one drug alone can attenuate the …

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS

BJ Turner, K Talbot - Progress in neurobiology, 2008 - Elsevier
Gain-of-function mutations in the Cu, Zn-superoxide dismutase (SOD1) gene are implicated
in progressive motor neuron death and paralysis in one form of inherited amyotrophic lateral …

Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury

M Lalancette-Hébert, V Swarup… - Journal of …, 2012 - Soc Neuroscience
Growing evidence suggests that galectin-3 is involved in fine tuning of the inflammatory
responses at the periphery, however, its role in injured brain is far less clear. Our previous …